
A long-established drug with a diverse medical history is drawing new attention for its potential role in treating an ultra-rare and life-threatening genetic disorder. Early findings suggest that a medicine first developed decades ago could take on an unexpected new role in treating Bachmann-Bupp syndrome (BABS), a devastating and ultra-rare condition with no established therapy. […]
Read more about this post…
Credits: Source
Disclaimer




Serving